Humira
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Lipitor lost market exclusivity has been that Humira (adalimumab) will top any biggestselling drug chart (Table 1). Indeed, such…
Quality by design (QbD) is an efficient but challenging approach for the development of biosimilar due to the complex…
ABSTRACT Background CinnoRA® (CinnaGen, Iran) is a biosimilar candidate for the reference adalimumab, Humira® (AbbVie, USA). This…
It's the best-selling drug by revenue worldwide and manufacturer AbbVie has worked hard to fend off competition. Very hard…
The Patent Trial and Appeal Board (PTAB) found all of the claims of three AbbVie Biotechnology Ltd. (AbbVie) patents directed to…
This article discusses the patent strategy underlying the world's best selling drug, AbbVie's Humira®. Despite a non-optimal…
Background TNFα inhibitors are highly effective drugs for the treatment of inflammatory disorders such as rheumatoid arthritis…
FDA-Approved Indications Moderately to severely active rheumatoid arthritis (RA) Moderately to severely active polyarticular…